Open House Discount Contracts 2024 07

Deadline: 30 Jun 2026

Germany

Ref. No.: 5653458

EMD:Ref Document

Bid Value: Ref Document

159 Days Left

Open House Biologics Discount Agreements 2024 02 Romiplostim

Deadline: 30 Jun 2026

Germany

Ref. No.: 5604853

EMD:Ref Document

Bid Value: Ref Document

159 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5599069

EMD:Ref Document

Bid Value: Ref Document

343 Days Left

Open House Biologics Discount Agreements 2024 03 Omalizumab

Deadline: 30 Jun 2026

Germany

Ref. No.: 5598331

EMD:Ref Document

Bid Value: Ref Document

159 Days Left

Open House Contracts For Several Active Ingredients Combinations Of Active Ingredients

Deadline: 04 May 2026

Germany

Ref. No.: 5598031

EMD:Ref Document

Bid Value: Ref Document

102 Days Left

Openhouse Procedure Various Active Pharmaceutical Ingredients From October 1St 2024

Deadline: 05 Aug 2026

Germany

Ref. No.: 5597729

EMD:Ref Document

Bid Value: Ref Document

195 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Sgb V With The Possibility Of Joining At Any Time So Called Approval Model 2024 05

Deadline: 05 May 2026

Germany

Ref. No.: 5508686

EMD:Ref Document

Bid Value: Ref Document

103 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5485044

EMD:Ref Document

Bid Value: Ref Document

343 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5460438

EMD:Ref Document

Bid Value: Ref Document

343 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5457173

EMD:Ref Document

Bid Value: Ref Document

343 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5450913

EMD:Ref Document

Bid Value: Ref Document

343 Days Left

Drug Contracts With An Option To Join

Deadline: 01 May 2026

Germany

Ref. No.: 5310892

EMD:Ref Document

Bid Value: Ref Document

99 Days Left

Open House Drug Discount Agreements Rivaroxaban Film Coated Tablets Except With A Strength Of 2 5 Mg Atc B01Af01

Deadline: 05 Apr 2026

Germany

Ref. No.: 5306291

EMD:Ref Document

Bid Value: Ref Document

73 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5266211

EMD:Ref Document

Bid Value: Ref Document

343 Days Left

Medicines With The Active Ingredient Fampridine Atc N07Xx07

Deadline: 31 Mar 2026

Germany

Ref. No.: 5229599

EMD:Ref Document

Bid Value: Ref Document

68 Days Left

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

FREE Trial plan for all new users!